Viscosupplement

5 marketed 1 in Phase 3 1 in Phase 2

This page covers all Viscosupplement drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Joint synovial fluid (viscoelastic properties), Synovial fluid replacement (non-receptor mediated), Hyaluronic acid receptor (CD44).

Targets

Joint synovial fluid (viscoelastic properties) · Synovial fluid replacement (non-receptor mediated) · Hyaluronic acid receptor (CD44)

Marketed (5)

Phase 3 pipeline (1)

Phase 2 pipeline (1)